Search Results1-9 of  9

  • Takano Toshimi ID: 9000380492761

    Articles in CiNii:1

    • Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer : a phase Ⅱ trial and biomarker study (WJOG7212G) (2018)
  • Takano Toshimi ID: 9000399574891

    Articles in CiNii:1

    • Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer : an exploratory analysis of the phase Ⅲ ABSOLUTE trial (2019)
  • Takano Toshimi ID: 9000403135272

    Articles in CiNii:1

    • Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild-type KRAS colorectal cancer-WJOG 6210G (2016)
  • TAKANO Toshimi ID: 9000014160567

    Division of Internal Medicine, National Cancer Center Hospital (2009 from CiNii)

    Articles in CiNii:2

    • Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma (2008)
    • Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non-small-cell lung cancer for gefitinib treatment (2009)
  • TAKANO Toshimi ID: 9000239644708

    Department of Medical Oncology, Toranomon Hospital (2013 from CiNii)

    Articles in CiNii:1

    • Care for women with cancer from the viewpoints of a medical oncologist (2013)
  • Takano Toshimi ID: 9000021915543

    Division of Internal Medicine, National Cancer Center Hospital (2009 from CiNii)

    Articles in CiNii:1

    • EGFR Mutation, But Not Sex and Smoking, Is Independently Associated with Favorable Prognosis of Gefitinib-treated Patients with Lung Adenocarcinoma (2009)
  • Takano Toshimi ID: 9000391551193

    The department of clinical oncology at Toranomon Hospital (2017 from CiNii)

    Articles in CiNii:1

    • The history of Granulocyte-colony stimulating factor (2017)
  • Takano Toshimi ID: 9000392015975

    National Cancer Center Hospital (2006 from CiNii)

    Articles in CiNii:1

    • Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, and mutation in EGFR in lung adenocarcinoma (2006)
  • Takano Toshimi/Yu Changmin ID: 9000329884912

    ASAHIKAWA UNIVERSITY (1991 from CiNii)

    Articles in CiNii:1

    • Yu Changmin : On the Kanshi ( Chinese poem ) in works of Ryunosuke Akutagawa (1991.8) (1991)
Page Top